Abstract:BACKGROUND:In vivo pig liver xenotransplantation preclinical trials appear to have poor efficiency compared to heart or kidney xenotransplantation because of xenogeneic rejection, including coagulopathy, and particularly thrombocytopenia. In contrast, ex vivo pig liver (wild type) perfusion systems have been proven to be effective in "bridging" liver failure patients until subsequent liver allotransplantation, and transgenic (human CD55/CD59) modifications have even prolonged the duration of pig liver perfusion. Despite the fact that hepatocyte cell lines have also been proposed for extracorporeal blood circulation in conditions of acute liver failure, porcine hepatocyte cell lines, and the GalT-KO background in particular, have not been developed and applied in this field. Herein, we established immortalized wild-type and GalT-KO porcine hepatocyte cell lines, which can be used for artificial liver support systems, cell transplantation, and even in vitro studies of xenotransplantation.METHODS:Primary hepatocytes extracted from GalT-KO and wild-type pigs were transfected with SV40 LT lentivirus to establish immortalized GalT-KO porcine hepatocytes (GalT-KO-hep) and wild-type porcine hepatocytes (WT). Hepatocyte biomarkers and function-related genes were assessed by immunofluorescence, periodic acid-Schiff staining, indocyanine green (ICG) uptake, biochemical analysis, ELISA, and RT-PCR. Furthermore, the tumorigenicity of immortalized cells was detected. In addition, a complement-dependent cytotoxicity (CDC) assay was performed with GalT-KO-hep and WT cells. Cell death and viability rates were assessed by flow cytometry and CCK-8 assay.RESULTS:GalT-KO and wild-type porcine hepatocytes were successfully immortalized and maintained the characteristics of primary porcine hepatocytes, including albumin secretion, ICG uptake, urea and glycogen production, and expression of hepatocyte marker proteins and specific metabolic enzymes. GalT-KO-hep and WT cells were confirmed as having no tumorigenicity. In addition, GalT-KO-hep cells showed less apoptosis and more viability than WT cells when exposed to complement and xenogeneic serum.CONCLUSIONS:Two types of immortalized cell lines of porcine hepatocytes with GalT-KO and wild-type backgrounds were successfully established. GalT-KO-hep cells exhibited higher viability and injury resistance against a xenogeneic immune response.

Large‐Scale Formation and Long‐Term Culture of Hepatocyte Organoids From Streamlined In Vivo Genome‐Edited GGTA1−/− Pigs for Bioartificial Liver Applications

Advances in cell sources of hepatocytes for bioartificial liver.

Three-dimensional culture of porcine hepatocytes for bioartificial liver

Bioartificial liver system based on choanoid fluidized bed bioreactor improve the survival time of fulminant hepatic failure pigs.

Establishment of gene‐edited pigs expressing human blood‐coagulation factor VII and albumin for bioartificial liver use

Establishment and Characterization of Immortalized Porcine Hepatocytes for the Study of Hepatocyte Xenotransplantation.

Immortalization of Porcine Hepatocytes with a Α‐1,3‐galactosyltransferase Knockout Background

Biological characteristics of suckling porcine hepatocytes for bioartificial liver

Morphology,viability and function of suckling pig hepatocytes in spheroid culture and cryopreservation for bioartificial liver system

Isolation and Short Term Cultivation of Swine Hepatocytes for Bioartificial Liver Support System.

Porcine Hepatocytes: Isolation and Liver Tissue Engineering for Xenotransplantation

Development of RAG2-/-IL2Rγ-/Y immune deficient FAH-knockout miniature pig

Configuration of a new bioartificial liver support system and in vitro evaluation of its functions.

Construction of a novel bioartificial liver system and its functional evaluation in vitro

Establishment and characterization of immortalized human hepatocyte cell line for applications in bioartificial livers

A clinical-scale BioArtificial Liver, developed for GMP, improved clinical parameters of liver function in porcine liver failure

Improved survival of porcine acute liver failure by a bioartificial liver device implanted with induced human functional hepatocytes

The significant improvement of survival times and pathological parameters by bioartificial liver with recombinant HepG2 in porcine liver failure model

A bioartificial transgenic porcine whole liver expressing human proteins alleviates acute liver failure in pigs

α-1,3-Galactosyltransferase knockout pig induced pluripotent stem cells: a cell source for the production of xenotransplant pigs

Selective germline genome edited pigs and their long immune tolerance in Non Human Primates